These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 26415518

  • 1. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
    Sokai A, Handa T, Tanizawa K, Oga T, Uno K, Tsuruyama T, Kubo T, Ikezoe K, Nakatsuka Y, Tanimura K, Muro S, Hirai T, Nagai S, Chin K, Mishima M.
    Respir Res; 2015 Sep 29; 16():120. PubMed ID: 26415518
    [Abstract] [Full Text] [Related]

  • 2. [Change of matrix metalloproteinase-1 and matrix metalloproteinase-7 in serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and sarcoidosis].
    Zhou LF, Jiang L, Li ZH, Kang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun 29; 33(6):441-4. PubMed ID: 20979817
    [Abstract] [Full Text] [Related]

  • 3. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
    Tzouvelekis A, Herazo-Maya JD, Slade M, Chu JH, Deiuliis G, Ryu C, Li Q, Sakamoto K, Ibarra G, Pan H, Gulati M, Antin-Ozerkis D, Herzog EL, Kaminski N.
    Respirology; 2017 Apr 29; 22(3):486-493. PubMed ID: 27761978
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M, Karpíšek M, Mazoch J, Skřičková J, Doubek M.
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct 07; 33(3):224-234. PubMed ID: 27758987
    [Abstract] [Full Text] [Related]

  • 5. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
    Morais A, Beltrão M, Sokhatska O, Costa D, Melo N, Mota P, Marques A, Delgado L.
    Respir Med; 2015 Aug 07; 109(8):1063-8. PubMed ID: 26174192
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.
    Todd JL, Vinisko R, Liu Y, Neely ML, Overton R, Flaherty KR, Noth I, Newby LK, Lasky JA, Olman MA, Hesslinger C, Leonard TB, Palmer SM, Belperio JA, IPF-PRO Registry investigators.
    BMC Pulm Med; 2020 Mar 14; 20(1):64. PubMed ID: 32171287
    [Abstract] [Full Text] [Related]

  • 9. Production and activation of matrix metalloproteinase 7 (matrilysin 1) in the lungs of patients with idiopathic pulmonary fibrosis.
    Fujishima S, Shiomi T, Yamashita S, Yogo Y, Nakano Y, Inoue T, Nakamura M, Tasaka S, Hasegawa N, Aikawa N, Ishizaka A, Okada Y.
    Arch Pathol Lab Med; 2010 Aug 14; 134(8):1136-42. PubMed ID: 20670133
    [Abstract] [Full Text] [Related]

  • 10. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
    Vuorinen K, Myllärniemi M, Lammi L, Piirilä P, Rytilä P, Salmenkivi K, Kinnula VL.
    APMIS; 2007 Aug 14; 115(8):969-75. PubMed ID: 17696954
    [Abstract] [Full Text] [Related]

  • 11. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
    Hamai K, Iwamoto H, Ishikawa N, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Ohshimo S, Fujitaka K, Hamada H, Hattori N, Kohno N.
    Dis Markers; 2016 Aug 14; 2016():4759040. PubMed ID: 27293304
    [Abstract] [Full Text] [Related]

  • 12. C-C Motif Chemokine Ligand 15 May Be a Useful Biomarker for Predicting the Prognosis of Patients with Chronic Hypersensitivity Pneumonitis.
    Watanabe M, Horimasu Y, Iwamoto H, Yamaguchi K, Sakamoto S, Masuda T, Nakashima T, Miyamoto S, Ohshimo S, Fujitaka K, Hamada H, Kohno N, Hattori N.
    Respiration; 2019 Aug 14; 98(3):212-220. PubMed ID: 31416084
    [Abstract] [Full Text] [Related]

  • 13. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.
    Kennedy B, Branagan P, Moloney F, Haroon M, O'Connell OJ, O'Connor TM, O'Regan K, Harney S, Henry MT.
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep 14; 32(3):228-36. PubMed ID: 26422568
    [Abstract] [Full Text] [Related]

  • 14. The predictors of mortality in IPF - Does emphysema change the prognosis?
    Tokgoz Akyıl F, Sevim T, Akman C, Aksoy E, Ağca M, Aktas O, Akyıl M.
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct 07; 33(3):267-274. PubMed ID: 27758993
    [Abstract] [Full Text] [Related]

  • 15. Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
    Huh JW, Kim DS, Oh YM, Shim TS, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Kim KR.
    Chest; 2008 May 07; 133(5):1101-6. PubMed ID: 18071010
    [Abstract] [Full Text] [Related]

  • 16. Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.
    Korthagen NM, van Moorsel CH, Barlo NP, Ruven HJ, Kruit A, Heron M, van den Bosch JM, Grutters JC.
    Respir Med; 2011 Jan 07; 105(1):106-13. PubMed ID: 20888745
    [Abstract] [Full Text] [Related]

  • 17. Serum CA 15-3 is increased in pulmonary fibrosis.
    Ricci A, Mariotta S, Bronzetti E, Bruno P, Vismara L, De Dominicis C, Laganà B, Paone G, Mura M, Rogliani P, Mastrangeldo M, Sciacchitano S, Saltini C.
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul 07; 26(1):54-63. PubMed ID: 19960789
    [Abstract] [Full Text] [Related]

  • 18. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M, Enomoto N, Mikamo M, Oyama Y, Kono M, Fujisawa T, Inui N, Nakamura Y, Suda T.
    Respir Med; 2016 May 07; 114():18-26. PubMed ID: 27109807
    [Abstract] [Full Text] [Related]

  • 19. [Changes of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the bronchoalveolar lavage fluid and the serum of patients with idiopathic pulmonary fibrosis].
    Wei LQ, Li ZH, Kang J, Hou XM, Yu RJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun 07; 29(6):399-402. PubMed ID: 17045024
    [Abstract] [Full Text] [Related]

  • 20. Change in serum marker of oxidative stress in the progression of idiopathic pulmonary fibrosis.
    Matsuzawa Y, Kawashima T, Kuwabara R, Hayakawa S, Irie T, Yoshida T, Rikitake H, Wakabayashi T, Okada N, Kawashima K, Suzuki Y, Shirai K.
    Pulm Pharmacol Ther; 2015 Jun 07; 32():1-6. PubMed ID: 25862941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.